Table 3.

Univariate and multivariate COX regression analysis for overall survival in the TCGA cohort.

Clinicopathologic factors	Univariate analysis			Multivariate analysis
	OR	95% CI	P-value	OR	95% CI	P-value
ETNK2 Expression (high vs. low)	1.539	1.013-2.338	0.043*	1.536	1.014-2.329	0.043*
Gender (female vs. male)	0.701	0.437-1.126	0.142		-
Age (>45 vs. <45)	0.032	0.010-0.105	<0.001*	0.031	0.009-0.100	<0.001*
Metastasis (yes vs. no)	0.646	0.155-2.685	0.548		-
Histological type (classical vs. others)	2.810	1.732-4.557	<0.001*	2.804	1.739-4.520	<0.001*
T stage (III/IV vs. I/II)	1.130	0.704-1.816	0.613		-
Disease stage (AJCC7) (III/IV vs. I/II)	59.953	17.291-207.880	<0.001*	66.615	20.101-220.761	<0.001*

* P<0.05